Case report reveals gingival hypertrophy in a patient with schizophrenia after aripiprazole treatment, suggesting the need for monitoring side effects.
This article presents the case of a 40-year-old female who presented with schizophrenia, with clinical features displaying auditory hallucinations, disorganized behavior, and heightened suspiciousness. The patient was prescribed the tablet aripiprazole and was lost to follow-up for a year. The patient revisited the hospital after 1 year with drug-induced gingiva hypertrophy, which is an uncommon observation in a patient on aripiprazole. This case underscores the importance of monitoring side effects in patients receiving antipsychotic medications and highlights a rare association with aripiprazole.
No takes yet. Share an insight, caveat, or question.
Kelkar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: